Featured News
AccessHope Study Confirms...
Cancer remains employers’ top unmanaged cost risk, yet new analysis of two studies shows it continues to lose daily executive focus to other health concerns, such as GLP‑1s and mental health. This mismatch is now driving a structural benefits gap that has a significant impact on costs and patient outcomes. Research conducted by AccessHope, a company expanding access to world-class cancer care, and Lantern, a leading specialty care platform, revealed that 94% of HR and benefits leaders believe that early expert intervention for cancer care improves outcomes and cuts costs. Yet, in a separate survery, only 6% say they use external oncology specialists for high-cost treatment decisions.
Read more